Ptc Therapeutics, Inc. · NASDAQ:PTCT

Schmertzler Michael sold 25,000 Ptc Therapeutics, Inc. shares (Form 4)

Traded Aug 26 to Aug 27, 2026 · Filed Aug 28, 2026

From Aug 26 to Aug 27, 2026, Schmertzler Michael (Director) sold 25,000 Ptc Therapeutics, Inc. shares at an average US$72.26 for US$1.81M under a trading plan, leaving 1,336,594 shares. Filed Aug 28, 2026 (Form 4).

Sold
25,000 shares
Price
US$72.26 average (US$71.55 to US$73.18)
Value
US$1.81M
Holding after
1,336,594 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 26, 2026Common StockSale6,874US$72.741,354,720Indirect
Aug 26, 2026Common StockSale5,626US$73.181,349,094Indirect
Aug 27, 2026Common StockSale11,890US$71.551,337,204Indirect
Aug 27, 2026Common StockSale610US$72.221,336,594Indirect

Source

View original at SEC

Related